Harmony Biosciences Holdings, Inc. · NASDAQ:HRMY
Budur Kumar sold 33,954 Harmony Biosciences Holdings, Inc. shares (Form 4)
Traded Sep 4 to Sep 8, 2026 · Filed Sep 9, 2026
From Sep 4 to Sep 8, 2026, Budur Kumar (CHIEF MEDICAL OFFICER) sold 33,954 Harmony Biosciences Holdings, Inc. shares at an average US$42.80 for US$1.45M, leaving 13,115 shares. Filed Sep 9, 2026 (Form 4).
- Sold
- 33,954 shares
- Price
- US$42.80 average (US$41.98 to US$43.10)
- Value
- US$1.45M
- Holding after
- 13,115 shares
- Trading plan
- No
- Role
- CHIEF MEDICAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | Sale | 5,500 | US$41.98 | 18,615 | Direct |
| Sep 8, 2026 | Common Stock | Sale | 4,500 | US$42.25 | 14,115 | Direct |
| Sep 8, 2026 | Common Stock | Sale | 1,000 | US$42.79 | 13,115 | Direct |
| Sep 8, 2026 | Common Stock | Option exercise | 12,200 | US$30.69 | 25,315 | Direct |
| Sep 8, 2026 | Common Stock | Option exercise | 10,754 | US$30.27 | 36,069 | Direct |
| Sep 8, 2026 | Common Stock | Sale | 22,954 | US$43.10 | 13,115 | Direct |
Source
Related
- Harmony Biosciences Holdings, Inc.
- Budur Kumar
- Harmony Biosciences Holdings, Inc. shareholders
- Form 4 · Budur Kumar · Sep 18, 2026
- Form 4 · Budur Kumar · May 18, 2026
- Schedule 13G · Vanguard Portfolio Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Zaeske Adam H. · Apr 9, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · FMR LLC · Feb 5, 2026